Global Cardiovascular Drugs Market 2018-2024

Cardiovascular Drugs Market Trends and Drivers, Restraints, and Opportunities 2018-2024

Cardiovascular diseases (CVD) are conditions related to the malfunction of heart and blood vessels. Some of the most common cardiovascular diseases are hypertensive heart disease, rheumatic heart disease, cerebrovascular heart disease, ischemic heart disease and inflammatory heart disease. Changing dietary habits, increasing consumption of tobacco & alcohol and pollution across the globe is estimated to rise the incidences of CVD’s during the forecasted period.

The Global Cardiovascular Drugs market is expected to witness rapid growth due to increase in aging population, prevalence of cardiovascular diseases, and the availability of generic drugs reducing the cost of treatment. On the basis of drug class, the market is segmented into anti hyperlipidemics, antihypertensives, antiarrhythmatics, anticoagulants, antifibrinolytics and other. The North America is expected to consume the largest share of the market, followed by Europe during the forecasted period. The growth in the APAC region is driven by largest geriatric population and obesity rate. Some of the most prominent players in the market include Bristol-Myers Squibb Company, Abbott Laboratories Inc., AstraZeneca PLC, Takeda Pharmaceutical Co. Ltd., Novartis AG, Forest Laboratories Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Daiichi Sankyo Co. Ltd., Pfizer Inc. and Solvay SA.

The report provides the complete details of various market trends and adoption rate in various segments and across the regions. The major trends, drivers, restraints, and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the cardiovascular drugs market.

This report also provides the competitive landscape of the leading players in Global Cardiovascular Drugs market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific info required by the users. The customization of the report is available based on countries, vendor profiles, enterprise and vertical wise.

Market Report Scope:

Healthcare Category: PHARMACEUTICAL

Product Type

  • Anti hyperlipidemics
  • Antihypertensive
  • Anti-coagulants
  • Antifibrinolytic
  • Antiarrhythmic
  • Others


  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Industry Outlook: Market Trends and Drivers, Restraints, and Opportunities

Request for TOC at

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Secondary & Primary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting


Market related information is congregated from both secondary and primary sources. Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

For more details on Research Methodology kindly click here to Engage with our Analyst.

Category :







Enquiry Hours